共 50 条
- [1] RESPONSE TO "STEREOTACTIC ABLATIVE RADIOTHERAPY IN THE FRAMEWORK OF CLASSICAL RADIOBIOLOGY: RESPONSE TO DRS. BROWN, DIEHN, AND LOO." (INT J RADIAT ONCOL BIOL PHYS 2011;79:1599-1600) AND "INFLUENCE OF TUMOR HYPOXIA ON STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR): RESPONSE TO DRS. MAYER AND TIMMERMAN." (INT J RADIATION ONCOL BIOL PHYS 2011;78:1600) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (04): : 1193 - 1193
- [2] In response to Drs. Timmerman and Mendonca INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (05): : 1580 - 1580
- [3] STEREOTACTIC ABLATIVE RADIOTHERAPY IN THE FRAMEWORK OF CLASSICAL RADIOBIOLOGY: RESPONSE TO DRS. BROWN, DIEHN, AND LOO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (05): : 1599 - 1600
- [6] Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer BRITISH JOURNAL OF RADIOLOGY, 2017, 90 (1070):
- [10] Stereotactic ablative radiotherapy (SABR) for patients with lung tumor and severe pulmonary function impairment CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (12): : 3246 - 3251